Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT00423332What this trial is testingCediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma AstraZeneca 105
Not applicableActive Not RecruitingNCT02735252What this trial is testingPROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerWho this might be right forProstate CancerAdvanced Renal Cell CarcinomaAdvanced Urothelial Carcinoma+1 more University of California, San Francisco 156
Early research (Phase 1)Ended earlyNCT03138538What this trial is testingM8891 First in Human in Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Renal Cell Carcinoma EMD Serono Research & Development Institute, Inc. 27
Early research (Phase 1)UnknownNCT06182735What this trial is testingCD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Fudan University 9
Testing effectiveness (Phase 2)Looking for participantsNCT07087158What this trial is testingIBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma (RCC) Imbioray (Hangzhou) Biomedicine Co., Ltd. 30
Early research (Phase 1)Study completedNCT00095108What this trial is testingStudy of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney CancerWho this might be right forMelanomaKidney NeoplasmsMetastases ZymoGenetics 43
Early research (Phase 1)Looking for participantsNCT06805825What this trial is testingThe c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitWho this might be right forGastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more Novelty Nobility, Inc. 67
Not applicableLooking for participantsNCT07557225What this trial is testing18F-T2 PET/CT Imaging for CAIX Positive Solid TumorsWho this might be right forClear Cell Renal Cell Cancer (ccRCC)Urothelial Carcinoma (UC)Colorectal Cancer+11 more Peking University First Hospital 200
Not applicableApproved For MarketingNCT00130897What this trial is testingTreatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Pfizer
Testing effectiveness (Phase 2)Active Not RecruitingNCT04071223What this trial is testingTesting the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL StudyWho this might be right forAdvanced Renal Cell CarcinomaChromophobe Renal Cell CarcinomaClear Cell Renal Cell Carcinoma+6 more National Cancer Institute (NCI) 134
Testing effectiveness (Phase 2)Study completedNCT01182142What this trial is testingStudy of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) PatientsWho this might be right forMetastatic Renal Cell Carcinoma Kidney Cancer Research Bureau 51
Testing effectiveness (Phase 2)Ended earlyNCT00082459What this trial is testingTrial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Agenus Inc. 40
Early research (Phase 1)Ended earlyNCT06034860What this trial is testingStudy of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesWho this might be right forNon Small Cell Lung CancerHepatocellular CarcinomaMelanoma+8 more Molecular Templates, Inc. 15
Post-approval studies (Phase 4)Study completedNCT00365508What this trial is testingCounseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingWho this might be right forBladder CancerCervical CancerEsophageal Cancer+8 more Fox Chase Cancer Center 642
Testing effectiveness (Phase 2)Study completedNCT03190174What this trial is testingNivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersWho this might be right forEwing SarcomaPEComaEpithelioid Sarcoma+11 more Sarcoma Oncology Research Center, LLC 34
Testing effectiveness (Phase 2)Study completedNCT03587662What this trial is testingIxazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney CancerWho this might be right forMetastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT02855203What this trial is testingStereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal TumoursWho this might be right forRenal Cell Carcinoma Peter MacCallum Cancer Centre, Australia 30
Testing effectiveness (Phase 2)UnknownNCT00025103What this trial is testingChemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the KidneyWho this might be right forKidney Cancer Children's Cancer and Leukaemia Group 75
Not applicableStudy completedNCT05112627What this trial is testingImmunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative TherapyWho this might be right forMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 Mayo Clinic 15